The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Context, Overview, Application, and Policy Implications

Providing safer, effective pain care has been a topic of significant debate as society navigates the current opioid misuse crisis. The legacy of aggressive opioid prescribing continues to affect both patients and providers even as opioid prescribing is at a 30 year low. The attempt to provide guidance surrounding opioid prescribing, via the 2016 CDC Guidelines, created unforeseen consequences. The patient’s voice was often eliminated, and the guideline misapplication led to forced tapers, inadequate acute pain control, and worsening mental health, including suicidality. This resulted in a multi-year revision based on patient, provider, and other stakeholder’s input. The 2022 CDC guidelines represent a significant refinement of 2016, are expanded to include all patient care settings, and prescribing guidance for both acute and chronic scenarios. They provide support in determining treatment, agent selection, duration, and assessing risk. This presentation will review each of the guidelines, the ‘why,’ and their potential impact. Shared decision making, individual patient risk assessment, and goal- directed care will also be reviewed. While a paucity of tools exists to fully operationalize risk benefit assessment, recommendations will be provided for providers, patients, and policy makers. Effective application, for both professional organizations and regulatory agencies, has the potential to improve quality of life and reduce burn-out for patients and their caregivers.
**In addition, research has shown that in the past five years, patients who are on long term opioids for chronic pain simply do not migrate towards fentanyl or other non-prescribed opioid use.

Learning Objectives:

  1. Understand the foundational components that the 2022 CDC are built upon.
  2. Learn how to apply the guidelines to best support our patients and system.
  3. Reduce stigma surrounding patients who require opioids for function.
  4. Explore how the guidelines formal adoption can support a variety of state-wide professional organizations policy implications.

Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.

Contact Hours
1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category I contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 contact hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.

 

Speakers

Date

Jun 25 2024

Time

12:00 pm - 1:00 pm

Location

Webinar

More Info

Register
Maine Substance Use Disorders Learning Community

Organizer

Maine Substance Use Disorders Learning Community